Steve Hopkinson

AbbVie has appointed Steve Hopkinson as UK Vice President

AbbVie has appointed Steve Hopkinson as Vice President and General Manager, UK.

Steve will succeed Todd Manning, who retires from AbbVie after 28 years, the last five of which have been in the UK Vice President and General Manager role.

Steve joined AbbVie in 2014 as UK Specialty Business Unit Director. He went on to lead AbbVie’s Immunology franchise in the UK and across Western Europe and Canada before taking on a General Manager role in the company’s Global Marketing and Commercial operations team.

He was promoted to his most recent position of European Area Commercial Head in 2022.

Commenting on his appointment, Steve said: “It is a privilege to take on this role at such a pivotal time for AbbVie. Thanks to Todd’s leadership our UK business and culture are strong, and we are well placed to bring the innovations from our robust pipeline to UK patients.

“I look forward to building on Todd’s achievements and working with stakeholders across the UK life sciences community, Govt and NHS to ensure the value of innovative medicines can be realised by the wider healthcare system.”

Prior to joining AbbVie, Steve worked at Otsuka Pharmaceuticals as European Digital Health and Access Director and at Lundbeck, where he was Head of Psychiatry.